CTOs on the Move

LeMaitre Vascular, Inc.

www.lemaitre.com

 
LeMaitre Vascular, Inc. (LeMaitre Vascular) is a provider of medical devices and implants for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

WellCare

WellCare Health Plans (NYSE: WCG) is a FORTUNE 500 company based in Tampa, Fla., employing more than 5,000 associates nationwide. WellCare has developed a full complement of expertise in the three major areas of government-sponsored health care…. Medicaid, Medicare Advantage and Medicare Prescription Drug Plans. Leveraging these for our members` benefit is a key part of the value we bring to our members. WellCare has a focus on those members who are dually eligible for both Medicaid and Medicare. This is an area of specialization that many other health plans simply do not have. We are committed to continually improving the quality of care and service that we provide to our members. We help our members access the right care at the right time in the appropriate setting through coordinated care teams and community partnerships. And we`re focused on government customers and use a disciplined approach to ensuring a competitive cost structure.

Sunlit Gardens Assisted Living

Sunlit Gardens Assisted Living is a Alta Loma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PAT Services

PAT Services is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Manor At Market Square

Manor at Market Square is a senior living community in Reading, PA that provides personal care assistance and 24 hour nursing care services.

Immune Design

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches designed to enable the body`s immune system to fight disease. The company`s technologies are engineered to activate the immune system`s natural ability to create tumor-specific cytotoxic T cells to fight cancer and other chronic disease. Immune Design`s clinical programs are the product of its two synergistic platforms: DCVexTM and GLAASTM.